ENZO BIOCHEM INC (ENZ) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 251 transactions totaling $13.0M, demonstrating a bearish sentiment with -$4.4M in net insider flow. The most recent transaction on Jul 24, 2024 involved a transaction of 70,885 shares valued at $82.9K.
No significant insider buying has been recorded for ENZ in the recent period.
No significant insider selling has been recorded for ENZ in the recent period.
Based on recent SEC filings, insider sentiment for ENZ is bearish with an Insider Alignment Score of 33/100 and a net flow of -$4.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ENZO BIOCHEM INC (ENZ) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading ENZ stock, having executed 251 transactions in the past 90 days. The most active insider is Shahram K. Rabbani (Executive), who has made 14 transactions totaling $4.9M.
Get notified when executives and directors at ENZ file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 24, 2024 | Cannon Kara | Executive | Payment | 70,885 | $1.17 | $82.9K | |
| Feb 23, 2024 | Cannon Kara | Executive | Award | 150,000 | $N/A | $0 | |
| Feb 21, 2024 | Cannon Kara | Executive | Payment | 5,823 | $N/A | $0 | |
| Feb 21, 2024 | Cannon Kara | Executive | Option Exercise | 10,640 | $N/A | $0 | |
| Jan 31, 2024 | Louis Radoff Bradley | Executive | Award | 79,365 | $N/A | $0 | |
| Jan 31, 2024 | Tagliaferri Mary | Executive | Award | 79,365 | $N/A | $0 | |
| Jan 31, 2024 | J. Pully Steven | Executive | Award | 79,365 | $N/A | $0 | |
| Oct 30, 2023 | J. Pully Steven | Executive | Award | 17,730 | $N/A | $0 | |
| Aug 31, 2023 | Cannon Kara | Executive | Payment | 63,700 | $1.54 | $98.1K | |
| Aug 31, 2023 | Cannon Kara | Executive | Award | 345,080 | $N/A | $0 | |
| Feb 13, 2023 | B. Walters Ian | Executive | Award | 75,188 | $N/A | $0 | |
| Feb 13, 2023 | G. Wolf James | Executive | Purchase | 5,000 | $1.29 | $6.5K | |
| Feb 13, 2023 | G. Wolf James | Executive | Purchase | 5,000 | $1.29 | $6.5K | |
| Feb 10, 2023 | G. Wolf James | Executive | Purchase | 5,000 | $1.29 | $6.5K | |
| Feb 9, 2023 | Louis Radoff Bradley | Executive | Award | 75,188 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 67 | $8.7M | 43.6% |
Purchase(P) | 50 | $4.3M | 21.5% |
Exercise(M) | 27 | $2.7M | 13.7% |
Payment(F) | 13 | $2.3M | 11.6% |
Conversion(C) | 18 | $1.5M | 7.5% |
Award(A) | 56 | $230.2K | 1.2% |
Disposition(D) | 6 | $160.9K | 0.8% |
Other(J) | 7 | $0 | 0.0% |
Gift(G) | 7 | $0 | 0.0% |
Insider selling pressure at ENZO BIOCHEM INC has increased, with 35 insiders executing 251 transactions across all time. Total sales of $8.7M significantly outpace purchases of $4.3M, resulting in a net outflow of $4.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.